SlideShare a Scribd company logo
DIABETES MELLITUS DURING
PREGNANCY
INTRODUCTION
• Diabetes mellitus is a chronic metabolic disorder due to either insulin
deficiency or due to peripheral tissue resistance (decreased sensitivity
to the action of insulin)
• The pathophysiology involved are:
Decreased sensitivity of skeletal muscles and liver to insulin (insulin
resistance) and
Inadequate secretion of insulin
Definitions
• Insulinopenia- resulting to a form of diabetes mellitus that results
from an inadequate secretion of insulin
• Hyperinsulinemia- the amount of insulin in your body is higher than
what is considered normal
• MODY- maturity onset diabetes of the young- a rare form of diabetes
which is caused by mutation
• Renal threshold- the lowest blood glucose level that correlated with
the first detectable appearance of urine glucose which is 180 mg/dl
(10.0 mmol/L)
TYPES OF DM
• Type–1 (IDDM) is characterized by young age onset (Juvenile) and
absolute insulinopenia. They have genetic predisposition with
presence of autoantibodies.
• Type–2 (NIDDM) is characterized by late age onset, overweight
woman and peripheral tissue (skeletal muscle, liver)insulin resistance
(hyperinsulinemia). Genetic predisposition is also observed.
• Gestational Diabetes Mellitus (GDM)
• Others: Genetic, Drugs, MODY
INCIDENCE OF DIABETES MELLITUS DURING
PREGNANCY
• About 1–14% of all pregnancies are complicated by diabetes mellitus
and 90% of them are gestational diabetes mellitus (GDM).
• Nearly 50% of women with GDM will become overt diabetes (type-2)
over a period of 5 to 20 years.
GESTATIONAL DIABETES MELLITUS (GDM)
NOMENCLATURE
• GDM is defined as carbohydrate intolerance of variable severity with onset
or first recognition during the present pregnancy.
• The entity usually presents late in the second or during the third trimester.
• The definition is used irrespective of the fact that the condition persists
after pregnancy or not.
• Majority of these women (>50%) with GDM ultimately develop overt
diabetes by next 15 to 20 years.
• It appears that many of these women diagnosed as GDM, are already
suffering from impaired b-cell function but remained undetected. These
cases are basically pre-existing type 2 diabetes.
CAUSES
• Insulin resistance whereby the body’s cells don’t use insulin well.
RISK FACTORS
• The potential candidates for GDM are:
• (a) Positive family history of diabetes (parents or sibling). Family history should
include uncles, aunts and grandparents.
• (b) Having a previous birth of an overweight baby of 4 kg or more
• (c) Previous stillbirth with pancreatic islet hyperplasia revealed on autopsy
• (d) Unexplained perinatal loss
• (e) Presence of polyhydramnios or recurrent vaginal candidiasis in present
pregnancy
• (f) Persistent glycosuria
• (g) Age over 30 years
• (h) Obesity
• (i) Ethnic group (East Asian, Pacific island ancestry).
CLINICAL MANIFESTATIONS
• Extreme thirst
• Fatigue
• Polyuria
• Glycosuria
• Blurred vision
• Nausea
SCREENING:
• While some advocate screening routinely to all pregnant mothers, others reserve
it only for the potential candidates.
• Screening strategy for detection of GDM are:
• (a) Low risk—Absence of any risk factors as mentioned above → blood glucose
testing is not routinely required
• (b) Average risk—Some risk factors → perform screening test
• (c) High risk—Blood glucose test as soon as feasible.
• The method employed is by using 50 gm oral glucose challenge test without
regard to time of day or last meal, between 24 weeks and 28 weeks of pregnancy.
• A plasma glucose value of 327 mg% or that of whole blood of 130 mg% at 1 hour
is considered as cut off point for consideration of a 100 gm (WHO– 75 gm)
glucose tolerance test
HAZARDS
• (1) Increased perinatal loss is associated with fasting hyperglycemia.
Fetal anomalies are however not increased. This is due to the absence
of metabolic disturbance during organogenesis
• (2) Increased incidence of macrosomia
• (3) Polyhydramnios
• (4) Birth trauma
• (5) Recurrence of GDM in subsequent pregnancies is about 50%.
MANAGEMENT
• Diet with 2,000–2,500 Kcal/day for normal weight woman and restriction
to 1,200–1,800 Kcal/day for over weight woman is recommended.
Carbohydrate should be 40–50% of total calories.
• The patient needs more frequent antenatal supervision with periodic
checkup of fasting plasma glucose level which should be less than 90 mg%.
• The control of high blood glucose is done by restriction of diet, exercise
with or without insulin.
• Human insulin (NovoRapid®) should be started if fasting plasma glucose
level exceeds 5.0mmol/L and 2 hours postprandial value is greater than
6.7mmol/L(repetitive) even on diet control.
• Nearly 25% women with GDM need insulin therapy.
• Exercise (aerobic, brisk walking) programs are safe in pregnancy and may
obviate the need of insulin therapy.
Obstetric management:
• Women with good glycemic control and who do not require insulin
may wait for spontaneous onset of labor. However, elective delivery
(induction or cesarean section) is considered in patients requiring
insulin or with complications (macrosomia) at around 38 weeks.
• Follow-up: Nearly 50% of women with GDM would develop overt
diabetes over a follow-up period of 5–20 years. Women with fasting
hyperglycemia have got worse prognosis to develop type-2 diabetes
and cardiovascular complications.
• Recurrence risk in subsequent pregnancy is more than 50%.
EFFECTS OF DIABETES ON PREGNANCY
• Abortion: Recurrent spontaneous abortion may be associated with
uncontrolled diabetes.
• Preterm labor (26%) may be due to infection or polyhydramnios.
• Infection: Urinary tract infection.
• Increased incidence of preeclampsia (25%).
• Polyhydramnios (25–50%) is a common association.
References
• Hiralal konar, DC Dutta’s textbook of obstetrics, 8th edition pg 325-334
• Marshal J, Raynor M, Myles textbook for midwives, 16th edition, pg
257-262

More Related Content

Similar to DIABETES MELLITUS DURING PREGNANCY.pptx

Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitus
yashaswi pathak
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
Brian Shiluli
 
Diabetes in pregnancy
Diabetes in pregnancy Diabetes in pregnancy
Diabetes in pregnancy
obgymgmcri
 
GDM.pptx
GDM.pptxGDM.pptx
Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)
Juliya Susan Reji
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
Dr ABU SURAIH SAKHRI
 
diabetes in pregnancy
diabetes in pregnancydiabetes in pregnancy
diabetes in pregnancy
sweetututu
 
Gestational Diabetes Endocrine course .pdf
Gestational Diabetes Endocrine course .pdfGestational Diabetes Endocrine course .pdf
Gestational Diabetes Endocrine course .pdf
Elhadi Miskeen
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptx
chishimbalouis1
 
GDM_ Dr Selim
GDM_ Dr SelimGDM_ Dr Selim
All about Gestational Diabetes Mellitus,
All about Gestational Diabetes Mellitus,All about Gestational Diabetes Mellitus,
All about Gestational Diabetes Mellitus,
ozhin araz
 
Gestational diabetes mellitus by sushant
Gestational diabetes mellitus by sushantGestational diabetes mellitus by sushant
Gestational diabetes mellitus by sushant
Sushant Yadav
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
Sabah Salim
 
The Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy DiabetesThe Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy Diabetes
Hanifullah Khan
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
susanta12
 
Diabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKADiabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKA
Stephen ram
 
Diabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKADiabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKA
Stephen ram
 
Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus (GDM)Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus (GDM)
sunil kumar daha
 

Similar to DIABETES MELLITUS DURING PREGNANCY.pptx (20)

Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitus
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
Diabetes in pregnancy
Diabetes in pregnancy Diabetes in pregnancy
Diabetes in pregnancy
 
GDM.pptx
GDM.pptxGDM.pptx
GDM.pptx
 
Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
 
diabetes in pregnancy
diabetes in pregnancydiabetes in pregnancy
diabetes in pregnancy
 
Gestational Diabetes Endocrine course .pdf
Gestational Diabetes Endocrine course .pdfGestational Diabetes Endocrine course .pdf
Gestational Diabetes Endocrine course .pdf
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptx
 
GDM_ Dr Selim
GDM_ Dr SelimGDM_ Dr Selim
GDM_ Dr Selim
 
All about Gestational Diabetes Mellitus,
All about Gestational Diabetes Mellitus,All about Gestational Diabetes Mellitus,
All about Gestational Diabetes Mellitus,
 
Gestational diabetes mellitus by sushant
Gestational diabetes mellitus by sushantGestational diabetes mellitus by sushant
Gestational diabetes mellitus by sushant
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
 
The Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy DiabetesThe Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy Diabetes
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
 
Diabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKADiabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKA
 
Diabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKADiabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKA
 
Gestational dm
Gestational dmGestational dm
Gestational dm
 
Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus (GDM)Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus (GDM)
 

Recently uploaded

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 

Recently uploaded (20)

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 

DIABETES MELLITUS DURING PREGNANCY.pptx

  • 2. INTRODUCTION • Diabetes mellitus is a chronic metabolic disorder due to either insulin deficiency or due to peripheral tissue resistance (decreased sensitivity to the action of insulin) • The pathophysiology involved are: Decreased sensitivity of skeletal muscles and liver to insulin (insulin resistance) and Inadequate secretion of insulin
  • 3. Definitions • Insulinopenia- resulting to a form of diabetes mellitus that results from an inadequate secretion of insulin • Hyperinsulinemia- the amount of insulin in your body is higher than what is considered normal • MODY- maturity onset diabetes of the young- a rare form of diabetes which is caused by mutation • Renal threshold- the lowest blood glucose level that correlated with the first detectable appearance of urine glucose which is 180 mg/dl (10.0 mmol/L)
  • 4. TYPES OF DM • Type–1 (IDDM) is characterized by young age onset (Juvenile) and absolute insulinopenia. They have genetic predisposition with presence of autoantibodies. • Type–2 (NIDDM) is characterized by late age onset, overweight woman and peripheral tissue (skeletal muscle, liver)insulin resistance (hyperinsulinemia). Genetic predisposition is also observed. • Gestational Diabetes Mellitus (GDM) • Others: Genetic, Drugs, MODY
  • 5. INCIDENCE OF DIABETES MELLITUS DURING PREGNANCY • About 1–14% of all pregnancies are complicated by diabetes mellitus and 90% of them are gestational diabetes mellitus (GDM). • Nearly 50% of women with GDM will become overt diabetes (type-2) over a period of 5 to 20 years.
  • 6. GESTATIONAL DIABETES MELLITUS (GDM) NOMENCLATURE • GDM is defined as carbohydrate intolerance of variable severity with onset or first recognition during the present pregnancy. • The entity usually presents late in the second or during the third trimester. • The definition is used irrespective of the fact that the condition persists after pregnancy or not. • Majority of these women (>50%) with GDM ultimately develop overt diabetes by next 15 to 20 years. • It appears that many of these women diagnosed as GDM, are already suffering from impaired b-cell function but remained undetected. These cases are basically pre-existing type 2 diabetes.
  • 7. CAUSES • Insulin resistance whereby the body’s cells don’t use insulin well.
  • 8. RISK FACTORS • The potential candidates for GDM are: • (a) Positive family history of diabetes (parents or sibling). Family history should include uncles, aunts and grandparents. • (b) Having a previous birth of an overweight baby of 4 kg or more • (c) Previous stillbirth with pancreatic islet hyperplasia revealed on autopsy • (d) Unexplained perinatal loss • (e) Presence of polyhydramnios or recurrent vaginal candidiasis in present pregnancy • (f) Persistent glycosuria • (g) Age over 30 years • (h) Obesity • (i) Ethnic group (East Asian, Pacific island ancestry).
  • 9. CLINICAL MANIFESTATIONS • Extreme thirst • Fatigue • Polyuria • Glycosuria • Blurred vision • Nausea
  • 10. SCREENING: • While some advocate screening routinely to all pregnant mothers, others reserve it only for the potential candidates. • Screening strategy for detection of GDM are: • (a) Low risk—Absence of any risk factors as mentioned above → blood glucose testing is not routinely required • (b) Average risk—Some risk factors → perform screening test • (c) High risk—Blood glucose test as soon as feasible. • The method employed is by using 50 gm oral glucose challenge test without regard to time of day or last meal, between 24 weeks and 28 weeks of pregnancy. • A plasma glucose value of 327 mg% or that of whole blood of 130 mg% at 1 hour is considered as cut off point for consideration of a 100 gm (WHO– 75 gm) glucose tolerance test
  • 11. HAZARDS • (1) Increased perinatal loss is associated with fasting hyperglycemia. Fetal anomalies are however not increased. This is due to the absence of metabolic disturbance during organogenesis • (2) Increased incidence of macrosomia • (3) Polyhydramnios • (4) Birth trauma • (5) Recurrence of GDM in subsequent pregnancies is about 50%.
  • 12. MANAGEMENT • Diet with 2,000–2,500 Kcal/day for normal weight woman and restriction to 1,200–1,800 Kcal/day for over weight woman is recommended. Carbohydrate should be 40–50% of total calories. • The patient needs more frequent antenatal supervision with periodic checkup of fasting plasma glucose level which should be less than 90 mg%. • The control of high blood glucose is done by restriction of diet, exercise with or without insulin. • Human insulin (NovoRapid®) should be started if fasting plasma glucose level exceeds 5.0mmol/L and 2 hours postprandial value is greater than 6.7mmol/L(repetitive) even on diet control. • Nearly 25% women with GDM need insulin therapy. • Exercise (aerobic, brisk walking) programs are safe in pregnancy and may obviate the need of insulin therapy.
  • 13. Obstetric management: • Women with good glycemic control and who do not require insulin may wait for spontaneous onset of labor. However, elective delivery (induction or cesarean section) is considered in patients requiring insulin or with complications (macrosomia) at around 38 weeks.
  • 14. • Follow-up: Nearly 50% of women with GDM would develop overt diabetes over a follow-up period of 5–20 years. Women with fasting hyperglycemia have got worse prognosis to develop type-2 diabetes and cardiovascular complications. • Recurrence risk in subsequent pregnancy is more than 50%.
  • 15. EFFECTS OF DIABETES ON PREGNANCY • Abortion: Recurrent spontaneous abortion may be associated with uncontrolled diabetes. • Preterm labor (26%) may be due to infection or polyhydramnios. • Infection: Urinary tract infection. • Increased incidence of preeclampsia (25%). • Polyhydramnios (25–50%) is a common association.
  • 16. References • Hiralal konar, DC Dutta’s textbook of obstetrics, 8th edition pg 325-334 • Marshal J, Raynor M, Myles textbook for midwives, 16th edition, pg 257-262